CompletedNot applicableNCT04646499

Feasibility of Gamma Transcranial Alternating Current Stimulation to Reduce Beta-amyloid Load and Improve Memory

Studying Amyloidosis

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
University of California, San Francisco
Principal Investigator
Theodore Zanto, Ph.D.
University of California, San Francisco
Intervention
Transcranial alternating current stimulation(device)
Enrollment
14 enrolled
Eligibility
55-80 years · All sexes
Timeline
2021 – 2022

Study locations (1)

Collaborators

National Institute on Aging (NIA)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04646499 on ClinicalTrials.gov

Other trials for Amyloidosis

Additional recruiting or active studies for the same condition.

See all trials for Amyloidosis →

← Back to all trials